胃酸過多症治療藥物市場規模、佔有率和成長分析：按藥物類別、劑型、分銷管道、處方類型、最終用戶和地區分類－產業預測，2026-2033年

2024 年全球治療胃酸過多的市場價值為 86.2 億美元，預計到 2025 年將成長至 91.1 億美元，到 2033 年將成長至 142 億美元，在預測期（2026-2033 年）內複合年成長率為 5.7%。

全球胃酸過多治療市場（包括處方藥和非處方藥）反映了胃食道逆流症 (GERD) 和消化性潰瘍等疾病日益普遍。這種不斷成長的消費者需求與生活方式的改變密切相關，例如高脂肪飲食、慢性壓力和人口老化。這個市場經歷了顯著的演變，從傳統的制酸劑轉向更先進的療法，例如質子幫浦阻斷劑(PPI) 和 H2 受體阻斷劑，這些療法能夠提供更持久的症狀緩解。新興市場可支配收入的增加和消化器官系統健康意識的提高，使得非處方 PPI 的可及性提高，這進一步推動了市場成長。此外，給藥方式的創新（例如緩釋膠囊）以及學名藥的成功上市表明，法規環境的改善和分銷管道的拓展如何支持市場擴張並刺激新的投資。

全球胃酸過多治療市場成長要素

全球胃酸過多治療市場正受到以下因素的推動：人們對導致胃酸逆流的生活方式因素的認知不斷提高，以及老年人口不斷成長，他們尋求有效的症狀緩解方案。消費者傾向於選擇非處方藥（OTC），因為這類藥物能夠快速緩解症狀且副作用較少，這促使生產商不斷擴大產品線。此外，醫療專業人員也擴大推薦這類藥物作為預防措施，也進一步推動了市場成長。消費者偏好和專家建議的結合，為不同地區和新興經濟體的市場成長創造了有利環境，凸顯了該市場對患者需求和臨床實踐的快速應對力。

全球胃酸過多治療市場面臨的限制因素

全球胃酸過多治療市場面臨許多限制因素，主要源自於監管機構嚴格的監管規定，這些規定要求藥物必須達到極高的安全性和有效性標準。這些要求延長了藥物研發週期，增加了遵循成本，迫使生產商進行全面的臨床試驗並應對複雜的文件流程。這些挑戰阻礙了中小企業的研發投入，可能導致產品上市延遲，並限制了新型創新製劑的市場准入。因此，市場主導地位往往集中在老牌企業手中，阻礙了整體成長，減緩了新療法的推出，並限制了市場競爭。

全球胃酸過多治療市場趨勢

全球胃酸過多症治療市場正呈現向個人化醫療顯著發展的趨勢。臨床醫生擴大根據患者的個別特徵（例如遺傳因素、腸道菌叢和生活方式）來選擇胃酸過多症治療方案。這種個人化方法不僅提高了治療效果，還最大限度地降低了不利事件的風險，與精準醫療的整體發展趨勢相契合。製藥公司正積極投資生物標記研究，並與診斷公司合作開發針對每位患者的個人化製劑。隨著以患者為中心的醫療模式日益受到重視，對個人化療法的需求預計將推動產品差異化，並在競爭激烈的市場中開闢新的商機。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球胃酸過多治療藥物市場規模：依藥物類別分類

• 制酸劑
• H2受體拮抗劑
• 質子幫浦阻斷劑
• 基於藻酸鹽的藥物

全球胃酸過多治療藥物市場規模：依劑型分類

• 藥片
• 膠囊
• 液體
• 咀嚼片

全球胃酸過多治療市場規模：按分銷管道分類

• 醫院藥房
• 零售藥房
• 網路藥房

全球胃酸過多治療市場規模：依處方類型分類

• OTC
• 處方

全球胃酸過多治療市場規模：依最終用戶分類

• 成人
• 兒童

全球胃酸過多症治療市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Haleon plc
• Bayer AG
• Johnson & Johnson
• Sanofi SA
• Pfizer Inc.
• Procter & Gamble Company
• Prestige Consumer Healthcare Inc.
• Church & Dwight Co., Inc.
• Reckitt Benckiser Group plc
• Sun Pharmaceutical Industries Limited
• Dr. Reddy's Laboratories Ltd.
• Torrent Pharmaceuticals Ltd.
• Alkem Laboratories Limited
• Abbott Laboratories
• Teva Pharmaceutical Industries Ltd.
• Viatris Inc.
• Perrigo Company plc
• Takeda Pharmaceutical Company Limited
• Aurobindo Pharma Limited
• Zydus Lifesciences Limited

結論與建議

Global Acid Indigestion Drug Market size was valued at USD 8.62 Billion in 2024 and is poised to grow from USD 9.11 Billion in 2025 to USD 14.2 Billion by 2033, growing at a CAGR of 5.7% during the forecast period (2026-2033).

The global market for acid indigestion drugs, including both prescription and over-the-counter options, reflects the increasing incidence of conditions like gastro-esophageal reflux disease and peptic ulcers. Rising consumer demand is linked to lifestyle changes such as high-fat diets, chronic stress, and aging populations. The market has evolved significantly, transitioning from traditional antacids to advanced solutions like proton-pump inhibitors (PPIs) and H2-blockers that offer longer-lasting relief. Growth is further fueled by enhanced access to OTC PPIs in emerging markets, driven by rising disposable incomes and heightened awareness of digestive health. Additionally, innovations in delivery methods, including delayed-release capsules, and the successful introduction of generics illustrate how regulatory improvements and wider distribution channels bolster market expansion and encourage new investments.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Acid Indigestion Drug market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Acid Indigestion Drug Market Segments Analysis

Global acid indigestion drug market is segmented by drug class, dosage form, distribution channel, prescription type, end user and region. Based on drug class, the market is segmented into Antacids, H2 Receptor Antagonists, Proton Pump Inhibitors and Alginates. Based on dosage form, the market is segmented into Tablets, Capsules, Liquids and Chewables. Based on distribution channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. Based on prescription type, the market is segmented into OTC and Prescription. Based on end user, the market is segmented into Adults and Pediatrics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Acid Indigestion Drug Market

The global acid indigestion drug market is driven by heightened awareness of lifestyle factors that contribute to acid reflux, alongside an increasing elderly population that demands effective relief from symptoms. Consumers are leaning towards over-the-counter options that offer quick relief with fewer side effects, encouraging manufacturers to expand their product offerings. Additionally, healthcare providers are increasingly recommending these medications as preventive measures, further boosting the market. This combination of consumer preferences and professional endorsements fosters a thriving environment for growth in the market across diverse geographical areas and emerging economies, highlighting the market's responsiveness to patient needs and clinical practices.

Restraints in the Global Acid Indigestion Drug Market

The Global Acid Indigestion Drug market faces significant restraints due to stringent regulations imposed by governing bodies that mandate high safety and efficacy standards. These requirements extend the time needed for drug development and elevate compliance expenses, leading manufacturers to undertake comprehensive clinical trials and manage intricate documentation processes. These challenges can lead to delays in product launches and restrict market access for new and innovative formulations, deterring smaller companies from pursuing research and development. As a result, market power tends to consolidate among established firms, impeding overall growth, slowing the introduction of new therapies, and limiting competitive dynamics.

Market Trends of the Global Acid Indigestion Drug Market

The Global Acid Indigestion Drug market is witnessing a notable trend towards the adoption of personalized therapies. Clinicians are increasingly choosing acid indigestion treatments based on individual patient characteristics, including genetics, microbiome profiles, and lifestyle factors. This personalized approach not only improves treatment efficacy but also minimizes the risk of adverse events, aligning with the broader movement towards precision medicine. Pharmaceutical companies are actively investing in biomarker research and collaborating with diagnostic firms to develop tailored formulations. As the focus on patient-centered care intensifies, the demand for customized regimens is anticipated to drive product differentiation and open new revenue opportunities in this competitive market.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Acid Indigestion Drug Market Size by Drug Class & CAGR (2026-2033)

• Market Overview
• Antacids
• H2 Receptor Antagonists
• Proton Pump Inhibitors
• Alginates

Global Acid Indigestion Drug Market Size by Dosage Form & CAGR (2026-2033)

• Market Overview
• Tablets
• Capsules
• Liquids
• Chewables

Global Acid Indigestion Drug Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Acid Indigestion Drug Market Size by Prescription Type & CAGR (2026-2033)

• Market Overview
• OTC
• Prescription

Global Acid Indigestion Drug Market Size by End User & CAGR (2026-2033)

• Market Overview
• Adults
• Pediatrics

Global Acid Indigestion Drug Market Size & CAGR (2026-2033)

• North America (Drug Class, Dosage Form, Distribution Channel, Prescription Type, End User)
  • US
  • Canada
• Europe (Drug Class, Dosage Form, Distribution Channel, Prescription Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Drug Class, Dosage Form, Distribution Channel, Prescription Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Drug Class, Dosage Form, Distribution Channel, Prescription Type, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Drug Class, Dosage Form, Distribution Channel, Prescription Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Haleon plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Procter & Gamble Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prestige Consumer Healthcare Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Church & Dwight Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reckitt Benckiser Group plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Torrent Pharmaceuticals Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alkem Laboratories Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viatris Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Perrigo Company plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aurobindo Pharma Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zydus Lifesciences Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations